Press Releases

Evolving strategies for successfully developing biosimilars and non-platformed therapeutics

Feb 14, 2013 15:28 GMT BioProcess International Europe Conference and Exhibition Next-generation therapies such as bi-specifics, fusion proteins and fragments offer tremendous benefits on paper, but it’s the bioprocessing departments that have to develop the new production methods, switch to new platforms and investigate new capture steps.

Feb 14, 2013 10:22 GMT Companiesandmarkets.com

Cell Culture Becomes an Integral Part of Cell Line Development and Engineering

Feb 11, 2013 15:44 GMT BioProcess International Europe Conference and Exhibition Market demands to reduce manufacturing costs require better Cell culture processes

Feb 05, 2013 16:25 GMT Magma Ceramics & Catalysts Magma Ceramics & Catalysts has appointed Martyn Gannon as its new Operations Director.

Deal making in the biosimilars market: increasing investment for decreasing return? - DataMonitor

Feb 05, 2013 08:09 GMT BioProcess International Europe Conference and Exhibition Biosimilars are big business. The global biologics market reached $125 billion in 2011, and is predicted to top $150 billion by the end of 2016. Of this, roughly $60 billion will be in off-patent sales.

ADC manufacturing made rapid progress over last five years, says Seattle Genetics

Jan 31, 2013 08:00 GMT BioProcess International Europe Conference and Exhibition Exclusive Interview with Nathan Ihle, Executive Director, Process Chemistry & Analytical Biochemistry, Seattle Genetics, USA

Peter Greenleaf steps down as MedImmune president, Bahija Jallal chosen as replacement

Dec 18, 2012 15:00 GMT Companiesandmarkets.com

Dec 17, 2012 16:30 GMT Companiesandmarkets.com

Dec 13, 2012 14:26 GMT Companiesandmarkets.com